Natural product and drugs interactions, its clinical implication in drug therapy management

Saudi Medical Journal

Volumn 29, Issue 3, 2008, Pages 333-339

  Joshi, Rupa ^a   Medhi, Bikash ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHYROID AGENT; ASTEMIZOLE; ATORVASTATIN; BISACODYL; CLONIDINE; CYCLOSPORIN; DIGOXIN; ERYTHROMYCIN; FELODIPINE; GINSENG EXTRACT; IRON; ITRACONAZOLE; KETOCONAZOLE; MEVINOLIN; MINERAL; NATURAL PRODUCT; NIFEDIPINE; NISOLDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIMVASTATIN; TERFENADINE; UNINDEXED DRUG; VITAMIN; VITAMIN K GROUP; WARFARIN;

ANKLE EDEMA; CARDIOVASCULAR DISEASE; CEREAL; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INFORMATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEVER; FIRST PASS EFFECT; FLUSHING; FOOD ANALYSIS; FOOD COMPOSITION; FOOD DRUG INTERACTION; FOOD INTAKE; GOITER; GRAPE JUICE; GRAPEFRUIT JUICE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; LIVER DISEASE; MILK; NONHUMAN; OAT; PAIN; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRESCRIPTION; PROTEIN FAMILY; QT PROLONGATION; RASPBERRY; REVIEW; RHUBARB; SIDE EFFECT; SPINACH; STRAWBERRY; SYNCOPE; TORSADE DES POINTES; VEGETABLE; BEVERAGE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG INTERACTION; DRUG THERAPY; GRAPEFRUIT; HEALTH FOOD; PHYTOTHERAPY;

BEVERAGES; CENTRAL NERVOUS SYSTEM; CITRUS PARADISI; DRUG INTERACTIONS; DRUG THERAPY; HEALTH FOOD; HUMANS; PHYTOTHERAPY;

EID: 47549094159     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 2004; 170: 1531-1532.
2. Gauthier I, Malone M. Drug-food interactions in hospitalised patients, methods of prevention. Drug Saf 1998; 18: 383-393.
3. Taliaferro PM. Adverse Drug-Drug and Food-Drug Medication Interactions HJuly 2001 [cited 2006 Oct 22]; Available from: URL: http://ohioline.osu.edu/ss-fact/0129.html
4. Scott GN, Elmer GW. Update an natural product-drug interactions. Am J Health Syst Pharm 2002; 59: 339-347.
5. Gonzalez FJ, Turkey RH. Drug Metabolism. In: Brunton LL, editor. The pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2006. p. 71-91.
6. Smolinske SC. Dietary supplement-drug interaction. J Am Med Women's Assoc 1999; 54: 191-192.
7. Spence JD. Drug interaction with grape fruit: Whose responsibility is it to warn the public. Clin Pharmacol Therap 1997; 61: 395-400.
8. Bailey DG, Arnold JM, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of maringin. Clin Pharmacol Ther 1993; 53: 637-642.
9. Bailey DG, Malcolm J, Arnold JMO, Spence JD. Grape fruit juice and drugs: How significant is the interaction? Clin Pharmacokinet 1994; 26: 91-98.
10. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268-269.
11. Kantola T, Kivisto KT, Neuvonen PJ. Grape fruit juice greatly increases serum concentration of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998; 63: 397-402.
12. Lilja JJ, Kivisto KT, Neuvonen PJ. Grape fruit juice increases serum concentration of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 1996; 66: 118-127.
13. Lilja JJ, Kinisto KT, Neuvonen PJ. Grape fruit juice- Simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid and HMG-CoA reductase inhibitors. Clin Parmacol Ther 1998; 64: 477-483.
14. Fuhr U, Kummert AL. The fate of naringin in humans: A key to grapefruit juice-drug interaction? Clin Pharmacol Ther 1995; 58: 365-373.
15. Honig PK, Wortham DC, Lazarev A, Cantilena LR. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J Clin Pharmacol 1996; 36: 345-351.
16. Zechnich AD, Hedges JR, Eiselt-Proteau D, Haxby D. Possible interactions with terfenadine or astemizole. West J Med 1994; 160: 321-325.
17. Flockhart DA. Drug interactions, cardiac toxicity, and terfenadine from bench to clinic? J Clin Psychopharmacol 1996; 16: 101-103.
18. Kohli K, Ali J, Ansari MJ, Raheman Z. Curcumin: A naural antiinflammatory agent. Indian J Pharmacol 2005; 37: 141-147.
19. Hoffman BB. Therapy of hypertension. In: Brunton LL, editor. The pharmacological basis of therapeutics. 11th ed. New York: McGraw Hill; 2006. p. 845-868.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
21. Morgan TO. Clinical use of potassium supplements and potassium sparing diuretics. Drugs 1973; 6: 222-229.
22. Cupp MJ. Herbal remedies: Adverse effect and drug interactions. Am Fam Physician 1999; 6: 1239-1245.
23. Yamreudeewong W, Henann NE, Fazio A, Lower DL, Cassidy TG. Drug- food interactions in clinical practice. J Family Pract 1995; 40: 376-384.
24. Musa MN, Lyons LL. Absorption and disposition of warfarin: Effects of foods and liquids. Curr Therap Res 1976; 20: 630-633.
25. Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand 1986; 220: 347-350.
26. Qureshi GD, Reinders TP, Swint JJ, Slate MB. Acquired warfatin resistance and weight reducing diet. Arch Intern Med 1981; 141: 507-509.
27. Natural Products-drug interactions. 2006 Oct [cited 2006 Nov 14]; WAvailable from: URL: www.musc.edu/pharmacyservices/medusepol/ naturalproddrug.Pdf
28. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 11th ed. Pune, India: Nirali Prakshan DK Furia; 1999. p. 141.
29. Thomas JA. Drug Nutrient Interactions. Nutrition Reviews 1995; 53: 271-382.
30. Mai I, Kruger H, Budde K, Johne A, Brockmoller J, Neumayer HH, et al. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther 2000; 38: 500-502.
31. Schmidt LE, Dalhoff K. Food-drug interactions. Drugs 2002; 62: 1481-1502.